Trademark: 90815184
Status Date
Tuesday, March 19, 2024
Filing Date
Wednesday, July 7, 2021
Published for Opposition
Tuesday, December 21, 2021
5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
Mar 19, 2024
Sou Extension Received With Teas Petition
Mar 19, 2024
Notice Of Revival - E-Mailed
Mar 19, 2024
Petition To Revive-Granted
Mar 19, 2024
Teas Petition To Revive Received
Mar 18, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 18, 2024
Abandonment - No Use Statement Filed
Aug 4, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 2, 2023
Sou Extension 3 Granted
Aug 2, 2023
Sou Extension 3 Filed
Aug 2, 2023
Sou Teas Extension Received
Feb 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 6, 2023
Sou Extension 2 Granted
Feb 6, 2023
Sou Extension 2 Filed
Feb 6, 2023
Sou Teas Extension Received
Feb 2, 2023
Teas Change Of Correspondence Received
Feb 2, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Feb 2, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 2, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 28, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 26, 2022
Sou Extension 1 Granted
Jul 26, 2022
Sou Extension 1 Filed
Jul 26, 2022
Sou Teas Extension Received
Jul 7, 2022
Teas Change Of Correspondence Received
Jul 7, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 7, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 15, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 21, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 21, 2021
Published For Opposition
Dec 1, 2021
Notification Of Notice Of Publication E-Mailed
Nov 12, 2021
Approved For Pub - Principal Register
Nov 12, 2021
Assigned To Examiner
Sep 15, 2021
New Application Office Supplied Data Entered
Jul 10, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
